NEOLEUKIN THERAPEUTICS INC's ticker is NLTX and the CUSIP is 64049K104. A total of 87 filers reported holding NEOLEUKIN THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.33 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $33,000 | -63.3% | 17,482 | -6.6% | 0.00% | – |
| Q4 2021 | $90,000 | -35.3% | 18,712 | -2.9% | 0.00% | -100.0% |
| Q3 2021 | $139,000 | -23.6% | 19,271 | -2.3% | 0.00% | 0.0% |
| Q2 2021 | $182,000 | -21.2% | 19,729 | +5.1% | 0.00% | 0.0% |
| Q1 2021 | $231,000 | -12.5% | 18,775 | +0.3% | 0.00% | 0.0% |
| Q4 2020 | $264,000 | +14.3% | 18,726 | -2.8% | 0.00% | 0.0% |
| Q3 2020 | $231,000 | -23.3% | 19,264 | +6.1% | 0.00% | 0.0% |
| Q2 2020 | $301,000 | – | 18,161 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 1,047,300 | $5,048,000 | 1.07% |
| ACT CAPITAL MANAGEMENT, LLC | 212,500 | $1,024,000 | 0.74% |
| Redmile Group, LLC | 3,490,835 | $16,826,000 | 0.38% |
| Kynam Capital Management, LP | 147,000 | $709,000 | 0.38% |
| EcoR1 Capital, LLC | 860,619 | $4,148,000 | 0.13% |
| Baker Brothers Advisors | 3,821,740 | $18,421,000 | 0.09% |
| GSA CAPITAL PARTNERS LLP | 130,899 | $631,000 | 0.08% |
| Sio Capital Management, LLC | 38,312 | $185,000 | 0.06% |
| Highland Private Wealth Management | 46,999 | $227,000 | 0.03% |
| XTX Topco Ltd | 10,018 | $48,000 | 0.03% |